RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Andrew Koppisch to Anti-Bacterial Agents

This is a "connection" page, showing publications Andrew Koppisch has written about Anti-Bacterial Agents.
Connection Strength

0.829
  1. Greene JR, Merrett KL, Heyert AJ, Simmons LF, Migliori CM, Vogt KC, Castro RS, Phillips PD, Baker JL, Lindberg GE, Fox DT, Del Sesto RE, Koppisch AT. Scope and efficacy of the broad-spectrum topical antiseptic choline geranate. PLoS One. 2019; 14(9):e0222211.
    View in: PubMed
    Score: 0.142
  2. Bartee D, Sanders S, Phillips PD, Harrison MJ, Koppisch AT, Freel Meyers CL. Enamide Prodrugs of Acetyl Phosphonate Deoxy-d-xylulose-5-phosphate Synthase Inhibitors as Potent Antibacterial Agents. ACS Infect Dis. 2019 03 08; 5(3):406-417.
    View in: PubMed
    Score: 0.135
  3. Sanders S, Bartee D, Harrison MJ, Phillips PD, Koppisch AT, Freel Meyers CL. Growth medium-dependent antimicrobial activity of early stage MEP pathway inhibitors. PLoS One. 2018; 13(5):e0197638.
    View in: PubMed
    Score: 0.129
  4. Sanders S, Vierling RJ, Bartee D, DeColli AA, Harrison MJ, Aklinski JL, Koppisch AT, Freel Meyers CL. Challenges and Hallmarks of Establishing Alkylacetylphosphonates as Probes of Bacterial 1-Deoxy-d-xylulose 5-Phosphate Synthase. ACS Infect Dis. 2017 07 14; 3(7):467-478.
    View in: PubMed
    Score: 0.121
  5. Zakrewsky M, Banerjee A, Apte S, Kern TL, Jones MR, Sesto RE, Koppisch AT, Fox DT, Mitragotri S. Choline and Geranate Deep Eutectic Solvent as a Broad-Spectrum Antiseptic Agent for Preventive and Therapeutic Applications. Adv Healthc Mater. 2016 06; 5(11):1282-9.
    View in: PubMed
    Score: 0.111
  6. Fox DT, Schmidt EN, Tian H, Dhungana S, Valentine MC, Warrington NV, Phillips PD, Finney KB, Cope EK, Leid JG, Testa CA, Koppisch AT. Sub-inhibitory fosmidomycin exposures elicits oxidative stress in Salmonella enterica serovar Typhimurium LT2. PLoS One. 2014; 9(4):e95271.
    View in: PubMed
    Score: 0.097
  7. Smith JM, Warrington NV, Vierling RJ, Kuhn ML, Anderson WF, Koppisch AT, Freel Meyers CL. Targeting DXP synthase in human pathogens: enzyme inhibition and antimicrobial activity of butylacetylphosphonate. J Antibiot (Tokyo). 2014 Jan; 67(1):77-83.
    View in: PubMed
    Score: 0.094
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support